Oncolytics Biotech Inc. financial statements
Oncolytics Biotech Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 28.76M | 10-K |
| Cash and equivalents | USD 5.2M | 10-Q |
| Total debt | USD 772.51K | EODHD |
Oncolytics Biotech Inc. financials on 6ix · Oncolytics Biotech Inc. on 6ix